These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10948698)

  • 1. [The prevention of bone mineral loss with hormonal replacement therapy in premenopausal women on dialysis with estrogen deficiency].
    Matuszkiewicz-Rowińska J; Skórzewska K; Radowicki S; Sokalski A; Niemczyk S; Wardyn K; Włodarczyk D; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 1999 Aug; 102(2):665-70. PubMed ID: 10948698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of hormone replacement therapy in pre-menopausal women with oestrogen deficiency on haemodialysis.
    Matuszkiewicz-Rowiñska J; Skórzewska K; Radowicki S; Sokalski A; Przedlacki J; Niemczyk S; Włodarczyk D; Puka J; Switalski M
    Nephrol Dial Transplant; 1999 May; 14(5):1238-43. PubMed ID: 10344368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal replacement therapy and lipid metabolism in women on hemodialysis with secondary to uremia estrogen deficiency].
    Matuszkiewicz-Rowińska J; Skórzewska K; Radowicki S; Sokalski A; Niemczyk S; Wardyn K; Bijak K; Przedlacki J; Ostrowski K
    Pol Arch Med Wewn; 1999 Aug; 102(2):671-6. PubMed ID: 10948699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in bone density in hemodialysed women treated with transdermal hormone replacement therapy].
    Radowicki S; Skórzewska K; Matuszkiewicz-Rowińska J
    Ginekol Pol; 2003 Sep; 74(9):997-1001. PubMed ID: 14674158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of salmon calcitonin on bone mineral density and calcium-phosphate metabolism in chronic hemodialysis patients with secondary hyperparathyroidism].
    Matuszkiewicz-Rowińska J; Niemczyk S; Przedlacki J; Puka J; Switalski M; Ostrowski K
    Pol Arch Med Wewn; 2004 Jul; 112(1):797-803. PubMed ID: 15526839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of estrogen therapy on bone mass in postmenopausal women with osteopenia].
    Insua A; Negri A; Zanchetta JR
    Medicina (B Aires); 1995; 55(5 Pt 1):408-14. PubMed ID: 8728770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The decrease in serum bone-specific alkaline phosphatase predicts bone mineral density response to hormone replacement therapy in early postmenopausal women.
    Dresner-Pollak R; Mayer M; Hochner-Celiniker D
    Calcif Tissue Int; 2000 Feb; 66(2):104-7. PubMed ID: 10652956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
    Heikkinen AM; Parviainen M; Niskanen L; Komulainen M; Tuppurainen MT; Kröger H; Saarikoski S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2476-82. PubMed ID: 9253321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
    Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
    J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bone metabolism in dialysis patient assessed by biochemical markers and densitometry].
    Małyszko J; Brzósko S; Wołczyński S; Małyszko JS; Myśliwiec M
    Pol Arch Med Wewn; 2003 Sep; 110(3):967-72. PubMed ID: 14699689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis.
    Hernández E; Valera R; Alonzo E; Bajares-Lilue M; Carlini R; Capriles F; Martinis R; Bellorin-Font E; Weisinger JR
    Kidney Int; 2003 Jun; 63(6):2269-74. PubMed ID: 12753317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus.
    Kipen Y; Briganti E; Strauss B; Will R; Littlejohn G; Morand E
    J Rheumatol; 1999 Feb; 26(2):310-7. PubMed ID: 9972964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of parathyroidectomy on bone mineral density in hemodialysis patients with secondary hyperparathyroidism: possible usefulness of preoperative determination of parathyroid hormone level for prediction of bone regain.
    Yano S; Sugimoto T; Tsukamoto T; Yamaguchi T; Hattori T; Sekita KI; Kaji H; Hattori S; Kobayashi A; Chihara K
    Horm Metab Res; 2003 Apr; 35(4):259-64. PubMed ID: 12778370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between bone turnover biomarkers, mandibular bone mineral density, and systemic skeletal bone mineral density in premenopausal and postmenopausal Indian women.
    Makker A; Singh MM; Mishra G; Singh BP; Jain GK; Jadhav S
    Menopause; 2012 Jun; 19(6):642-9. PubMed ID: 22240638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
    Tuppurainen MT; Komulainen M; Kröger H; Honkanen R; Jurvelin J; Puntila E; Heikkinen AM; Alhava E; Saarikoski S
    Osteoporos Int; 1998; 8(1):32-8. PubMed ID: 9692075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen and peptide YY are associated with bone mineral density in premenopausal exercising women.
    Scheid JL; Toombs RJ; Ducher G; Gibbs JC; Williams NI; De Souza MJ
    Bone; 2011 Aug; 49(2):194-201. PubMed ID: 21549231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.